In addition, SETMAR interaction with TOP2A has been found to enhance TOP2A function in chromosome decatenation and to promote resistance to topoisomerase II inhibitors in breast cancer cells (Figure 4B) [15,16]. The gene discussed is SETMAR; the disease is breast carcinoma.